INVO - INVO BioScience GAAP EPS of -$0.23 beats by $0.01 revenue of $0.14M misses by $0.19M
- INVO BioScience press release ( NASDAQ: INVO ): Q2 GAAP EPS of -$0.23 beats by $0.01 .
- Revenue of $0.14M (-33.3% Y/Y) misses by $0.19M .
- As of June 30, 2022, the Company had approximately $2.0 million in cash.
For further details see:
INVO BioScience GAAP EPS of -$0.23 beats by $0.01, revenue of $0.14M misses by $0.19M